GLP-1 Signaling
Cross-source consensus on GLP-1 Signaling from 1 sources and 4 claims.
1 sources · 4 claims
How it works
Risks & contraindications
Highlighted claims
- When estrogen falls during perimenopause or menopause, GLP-1 secretion drops, reducing satiety signaling and causing persistent hunger even after adequate meals. — Menopause, the Gut-Estrogen Axis, and Methylation: A Clinical Guide
- GLP-1 agonists such as semaglutide and tirzepatide mechanistically compensate for estrogen-driven GLP-1 suppression by directly activating GLP-1 receptors. — Menopause, the Gut-Estrogen Axis, and Methylation: A Clinical Guide
- By age 45–55, 65% of women meet criteria for obesity, rising to 75% after age 65, substantially driven by hormonal GLP-1 suppression. — Menopause, the Gut-Estrogen Axis, and Methylation: A Clinical Guide
- Phytoestrogens including berberine, cinnamon, and soy isoflavones support GLP-1 secretion through the ER Alpha pathway. — Menopause, the Gut-Estrogen Axis, and Methylation: A Clinical Guide